Tetracycline + Trastuzumab Qyyp Interaction
Majorinteraction on record
Description
Patients receiving anthracyclines after stopping trastuzumab may have increased risk of cardiac dysfunction due to trastuzumab's long washout period. Avoid anthracycline-based therapy for up to 7 months after stopping trastuzumab; if used, closely monitor cardiac function.
Mechanism
Trastuzumab's long washout period may potentiate anthracycline-induced cardiac toxicity
Source: NLP:trastuzumab-qyyp